From Simple English Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Novavax, Inc., is an American biotechnology company based in Gaithersburg, Maryland that creates vaccines to fight against serious infectious diseases. Before to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases.

During 2020, however, the company redirected its efforts to focus on development and approval of a vaccine for COVID-19.[1]

References[change | change source]

  1. Novavax Inc. 2020 Annual Report. Accessed 10 May 2021.